Table of Contents: IAVI Report

VAX is a monthly bulletin published by the International AIDS Vaccine Initiative (IAVI) featuring shorter, nontechnical versions of articles from the IAVI Report. VAX is currently available in English, French, German, Portuguese, and Spanish as a pdf or an e-mail bulletin. If you would like to receive VAX by e-mail, please send a request including language preference to: iavireport@iavi.org.

The Vax bulletin is available in

English (HTML and PDF),

Chinese (PDF),

Deutsch (PDF),

Français (PDF),

Español (PDF), and

Português (PDF).

VAX 2009 Nov; 7(12)

SPOTLIGHT: A Year of Progress: On World AIDS Day, scientists mark a promising year on both research and policy fronts
GLOBAL NEWS: New HIV Infections Steadily Declining
GLOBAL NEWS: Microbicide Gel Fails to Protect
PRIMER: Understanding Vaccine Licensure: What factors do regulatory bodies consider before licensing a vaccine for public use?

VAX 2009 Nov; 7(11)

SPOTLIGHT: Deadly Synergy
GLOBAL NEWS: Economy Threatens World Progress on Immunization
GLOGAL NEWS: WHO Meeting to Evaluate Test-and-Treat Strategy
PRIMER: Understanding the Hunt for Immune Correlates of Protection from RV144

VAX 2009 Oct; 7(10)

SPOTLIGHT: Vaccine Research Gains Momentum
PRIMER: Understanding the Statistical Analysis of Clinical Trial Results: What are some of the statistical methods that are used to interpret AIDS vaccine trial results?

VAX 2009 Sep; 7(9)

SPOTLIGHT: First Evidence of Efficacy from Large-Scale HIV Vaccine Trial
PRIMER: Understanding Challenge Viruses: How does the choice of challenge virus affect the outcome of vaccine studies in nonhuman primates?

VAX 2009 Aug; 7(8)

SPOTLIGHT: Everything from Cause to Cure
GLOBAL NEWS: South African AIDS Vaccine Initiative Launches Phase I Trial
PRIMER: Understanding the Role of Social Science Research in Clinical Trials: What can researchers learn from studying communities in preparation for AIDS vaccine clinical trials?

VAX 2009 Jul; 7(7)

SPOTLIGHT: Test and Treat on Trial
GLOBAL NEWS: Phase II Prime-Boost Trial Begins in the US
PRIMER: Understanding Inclusion/Exclusion Criteria: What are some of the eligibility requirements for volunteers to participate in AIDS vaccine clinical trials?

VAX 2009 Jun; 7(6)

SPOTLIGHT: Not Sure? Ask Everyone
GLOBAL NEWS: AVAC Reports on the HIV Prevention Puzzle
GLOBAL NEWS: New South Africa Institute to Tackle HIV and TB
PRIMER: Understanding Data Collection in AIDS Vaccine Clinical Trials: What are the methods used to ensure that data from AIDS vaccine trials are of high quality?

VAX 2009 May; 7(5)

SPOTLIGHT: Despite Recession, New Funding Stimulates Research
GLOBAL NEWS: World AIDS Vaccine Day Observed
GLOBAL NEWS: New iavireport.org Launches
PRIMER: Understanding How Partially Effective Vaccine Candidates are Evaluated: What are some of the complications in designing trials to study partially effective AIDS vaccine candidates?

VAX 2009 Apr; 7(4)

SPOTLIGHT: Capsules from Keystone: A broad collection of updates at this year's joint symposia served to inform the development of future AIDS vaccine candidates
GLOBAL NEWS: CAVD Reports Progress Toward AIDS Vaccine Development; Researchers Catch HIV on Film
PRIMER: Understanding the Transmitted Virus: What are researchers learning about the enemy that a preventive AIDS vaccine would need to block—the virus that is transmitted and establishes infection?

VAX 2009 Mar; 7(3)

SPOTLIGHT: It Eradicated Smallpox, But How?: Researchers are collecting clues about the protection afforded by the smallpox vaccine, the gold standard of vaccines
GLOBAL NEWS: Kenya AIDS Vaccine Initiative Marks 10-year Anniversary
PRIMER: Understanding How Inserts for Vaccine Candidates are Designed

VAX 2009 Feb; 7(2)

SPOTLIGHT: Canvassing CROI: HIV prevention strategies stoke excitement at recent scientific meeting
GLOBAL NEWS: $100 million Gift Creates New AIDS Vaccine Research Institute; Two Phase I Trials Launched
PRIMER: Understanding How Immune Responses to AIDS Vaccine Candidates are Measured: What are the limitations of current methods used to analyze immune responses to AIDS vaccine candidates and what new strategies are being explored?

VAX 2009 Jan; 7(1)

In With the New...
CDC, PEPFAR, and UNAIDS to Have New Leaders
Understanding the Conundrum of Immune Activation in HIV/AIDS

IAVI Report

IAVI Report is a publication on international AIDS vaccine research published bi-monthly by the International AIDS Vaccine Initiative (IAVI).

IAVI Report 2009 Nov/Dec; 13(6)

Visualizing HIV
Monkey Models
The Beauty Behind the Beasts
A Cut Above the Rest
Vaccine Briefs

IAVI Report 2009 Sep/Oct; 13(5)

The Mysteries of Protection
Raft of Results Energizes Researchers
RV144 in Detail
Deadly Synergy
Vaccine Briefs

IAVI Report 2009 Jul/Aug; 13(4)

Editor's Letter
Everything from Cause to Cure
Looking for the Perfect Challenge
Test and Treat on Trial
Vaccine Briefs
Research Briefs

IAVI Report 2009 May/Jun; 13(3)

Editor's Letter
Not Sure? Ask Everyone
Despite Recession, New Funding Stimulates Scientific Research
Vaccine Briefs
Research Briefs

IAVI Report 2009 Mar/Apr; 13(2)

Editor's Letter
Capsules from Keystone: A broad collection of updates at this year's joint symposia served to inform the development of future AIDS vaccine candidates
A Living History of AIDS Vaccine Research: Anthony Fauci talks about the quest for an AIDS vaccine in the first chapter of this special series
Vaccine Briefs: The Collaboration for AIDS Vaccine Discovery reports progress; The Kenya AIDS Vaccine Initiative marks 10-year anniversary
Research Briefs: CMV-based vaccine candidate protects macaques from systemic infection; Microbicide inhibits innate immune response; Researchers catch HIV on film

IAVI Report 2009 Jan/Feb; 13(1)

Highlights from CROI
In With the New...
Perspective: Challenges Facing Young Investigators
It Eradicated Smallpox, But How?
Vaccine Briefs
Research Briefs

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©2009. AEGiS.